These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32211325)

  • 1. The Clinicopathological Risk Factors in Renal Cell Cancer for the Oncological Outcomes Following Nephron-Sparing Surgery: A PRISMA Systematic Review and Meta-Analysis.
    Zhang L; Wu B; Zha Z; Qu W; Zhao H; Yuan J
    Front Oncol; 2020; 10():286. PubMed ID: 32211325
    [No Abstract]   [Full Text] [Related]  

  • 2. The Correlation of Clinicopathological Features With the Status of Surgical Margins in Renal Cell Cancer Patients Following Nephron-Sparing Surgery: A Systematic Review and Meta-Analysis.
    Zhang L; Wu B; Zha Z; Zhao H; Yuan J; Feng Y
    Front Oncol; 2019; 9():648. PubMed ID: 31380284
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis.
    Zhang L; Wu B; Zha Z; Qu W; Zhao H; Yuan J
    BMC Cancer; 2019 Jul; 19(1):716. PubMed ID: 31324162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis.
    Zhang L; Wu B; Zha Z; Zhao H; Yuan J; Jiang Y
    World J Urol; 2020 Jan; 38(1):129-142. PubMed ID: 30919100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value and clinicopathological features of sarcomatoid differentiation in patients with renal cell carcinoma: a systematic review and meta-analysis.
    Zhang L; Wu B; Zha Z; Zhao H; Feng Y
    Cancer Manag Res; 2018; 10():1687-1703. PubMed ID: 29970967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.
    Lau WK; Blute ML; Weaver AL; Torres VE; Zincke H
    Mayo Clin Proc; 2000 Dec; 75(12):1236-42. PubMed ID: 11126830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes.
    Bigot P; Hétet JF; Bernhard JC; Fardoun T; Audenet F; Xylinas E; Ploussard G; Pignot G; Bessede T; Ouzaid I; Robine E; Brureau L; Merigot de Treigny O; Maurin C; Long JA; Rouffilange J; Hoarau N; Lebdai S; Rouprêt M; Bastien L; Neuzillet Y; Mongiat-Artus P; Verhoest G; Zerbib M; Ravery V; Rigaud J; Bellec L; Baumert H; Chautard D; Bensalah K; Escudier B; Paparel P; Grenier N; Rioux-Leclercq N; Azzouzi AR; Soulié M; Patard JJ
    Clin Genitourin Cancer; 2014 Feb; 12(1):e19-27. PubMed ID: 24210610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive surgical margins are predictors of local recurrence in conservative kidney surgery for pT1 tumors.
    Marchiñena PG; Tirapegui S; Gonzalez IT; Jurado A; Gueglio G
    Int Braz J Urol; 2018; 44(3):475-482. PubMed ID: 29368873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pathological T3a upstaging on oncological outcomes of clinical T1 renal cell carcinoma: a meta-analysis.
    Chen L; Deng W; Liu X; Wang G; Fu B
    J Cancer; 2019; 10(20):4998-5006. PubMed ID: 31598172
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis.
    Zhang L; Zha Z; Qu W; Zhao H; Yuan J; Feng Y; Wu B
    BMC Cancer; 2018 Sep; 18(1):870. PubMed ID: 30176824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.
    Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X
    PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
    Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
    Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
    Blute M; Thibault GP; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whether histologic subtyping affect the oncological outcomes of patients with papillary renal cell carcinoma: evidence from a systematic review and meta-analysis.
    Xiong S; Zhu W; Li X; Yu Y; Yang K; Zhang L; Mi Y; Li X; Zhou L
    Transl Androl Urol; 2021 Aug; 10(8):3255-3266. PubMed ID: 34532250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
    Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
    Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
    Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
    BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals.
    Wang Z; Xie H; Guo L; Cai Q; Shang Z; Jiang N; Niu Y
    Cancer Manag Res; 2017; 9():679-689. PubMed ID: 29200888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of radical nephrectomy versus nephron-sparing surgery on localized renal cell carcinoma.
    Li W; Cheng Y; Cheng Y; Ren H; Han N
    Eur J Med Res; 2014 Nov; 19(1):58. PubMed ID: 25374003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.